Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Fidelity D & D Bancorp, Inc. Reports Third Quarter 2026 Financial Results
-
Invivyd Presents VMS063, a Potential Best-in-Class Monoclonal Antibody Candidate for the Treatment and Prevention of Measles, at IDWeek 2026
-
Labrador Gold Announces Extension of Non-Brokered Private Placement
-
Stifel Reports Third Quarter 2026 Results
-
Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness
-
Sundance Biosciences Announces Presentation of Phase 1 Results for SUN-627, a Brain-Penetrant TYK2 Inhibitor for the Treatment of Multiple Sclerosis (MS)
-
BioCryst Announces U.S. FDA Approval of ORLADEYO® 150 mg Oral Pellets for Adults and Adolescents with HAE
-
Xali Gold Completes FTA Application for Drilling and Outlines Development Team for Pico Machay
-
Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2026 Results
-
Auddia Announces Completion of LT350 Phase 1 Feasibility Study and Advancement to Phase 2/3 Engineering with Fresh Consulting
-
Jade Biosciences to Highlight Advancement of JADE101 Development Program at American Society of Nephrology (ASN) Kidney Week 2026
-
Aya Gold & Silver Files Updated Preliminary Economic Assessment Technical Report for Boumadine Project
-
Elion Therapeutics to Present Turletricin Clinical Data at IDWeek 2026
-
Micron Biomedical Awarded Federal Vaccine Contract to Fight Rotavirus Through The Skin, Without Needles
-
GOWell Energy Technology Reports Operating Subsidiary’s First Half 2026 Financial Results and Provides Corporate Update
-
Vivos Therapeutics Reports Nasdaq Confirmation of Compliance with Continued Listing Shareholders’ Equity Standard
-
Roivant and Priovant Announce Positive Results in CLARITY-1 and CLARITY-2 Phase 3 Trials for Brepocitinib in Non-Infectious Uveitis (NIU)
-
Immunovant to Report Financial Results for the Second Fiscal Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
-
Reborn Coffee Signs Master Product Supply Agreement with Visvita Corporation
-
Sotera Health Announces Third-Quarter 2026 Earnings Release Date
-
Old National Bancorp Reports Record Third Quarter 2026 Results
-
Agility Robotics Expands Pittsburgh Presence to Support Growing Customer Deployments
-
Winnebago Industries Reports Fourth Quarter and Full Year Fiscal 2026 Results
-
PyroGenesis Announces Dubai Subsidiary to Address Growing Opportunities in Middle East and Asian Markets
-
Aeluma Announces Primit Parikh as Strategic Advisor
-
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
-
West Ham United F.C. and BrewDog Unveil Boleyn Brew: A Fan-Created Matchday Beer Made by Hammers, for Hammers
-
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2026, and Provide Business Update on Monday, November 9, 2026
-
OTC Markets Group Names Meighan McGowan Executive Vice President, Corporate Services
-
Arteris to Announce Financial Results for the Third Quarter 2026 on Thursday, November 5, 2026
-
Human Feedback Foundation, with support from RBC, launches the Agentic AI Design Exchange to help Canadian nonprofits design their own AI agents
-
Entrada Therapeutics Appoints Linea Aspesi as Chief People Officer
-
Kaltura to Announce Financial Results for Third Quarter 2026 on Monday, November 9, 2026
-
Satellos to Participate in Upcoming Investor Conferences
-
Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto
-
Psyence BioMed Completes PsyLabs Investment as Ibogaine Milestones Are Met
-
Notification of share transactions by Lumen Investments S.à r.l
-
Artea Bank Invitation to 9 months 2026 Financial Results Webinar
-
Sitryx to Participate in Upcoming Investor Conferences
-
REGO Guardian Gives Platforms Verified Parental Consent Through a Single API
-
YieldMax® ETFs Announces Weekly Distributions for Group 2 ETFs
-
Magna Mining Reports Results of Crean Hill Pre-Feasibility Study With Construction to Begin in 2027
-
Form 8.5 (EPT/RI)-Logistics Development Group plc
-
Injective Collaborates with BDACS to Bring Korea's First Won-Backed Stablecoin to Onchain RWAs
-
Injective Collaborates with BDACS to Bring Korea's First Won-Backed Stablecoin to Onchain RWAs
-
Form 8.5 (EPT/RI) - Advanced Medical Solutions Group plc
-
NVIDIA and Supply Chain Partners Expand Capacity to Accelerate AI Infrastructure Buildout
-
U.S. Government Commits Nearly $250 Million to Port Mackenzie Rail Infrastructure, Supporting Alaska’s Resource development and providing a direct transport link to Nova Minerals planned critical mi
-
Korai Flix Inc. and APEX Tech Acquisition Inc. Agree to Merge and Create a Publicly Listed, Interactive Online Entertainment Platform
-
Parsons Receives Defense Innovation Unit Success Memo For PFAS Remediation
